Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes
Open accessThe DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver (NAFL) is an independent risk factor for the development of type 2 diabetes (T2DM). We examined metabolic perturbations in patients with NAFL, patients with T2DM, and control (CON) subjects with normal intrahepatic lipid (IHL) content. A two-step (10 mU/m2 /min; 40 mU/m2/min) hyperinsulinemic–euglycemic clamp was performed in 11 NAFL, 13 T2DM, and 11 CON subjects, all matched for BMI, and aerobic fitness. IHL content was measured using proton magnetic resonance spectroscopy. Because of high IHL content variability in T2DM patients, this group was separated into a high IHL content group (IHL ≥ 5.0%, T2DM+NAFL) and a normal IHL content group (IHL < 5.0%, T2DM-non-NAFL) for further analysis. IHL content was increased in NAFL and T2DM+NAFL subjects (P<0.050 versus CON and T2DM-non-NAFL subjects). Adipose tissue insulin sensitivity index (Adipo-IRi) was higher in NAFL (P<0.050 versus CON and T2DM-non-NAFL subjects) and in T2DM+NAFL subjects (P=0.055 versus CON subjects, P<0.050 versus T2DM-non-NAFL subjects). Suppression of plasma-free fatty acids (P=0.046) was lower in NAFL compared with CON subjects, with intermediate values for T2DM-non-NAFL, and T2DM+NAFL subjects. Suppression of endogenous glucose production (EGP) and insulin-stimulated glucose disposal (ΔRd) was comparable between NAFL, T2DM-non-NAFL, and T2DM+NAFL subjects (all P>0.05), and was lower in comparison with CON subjects (all P<0.01). Metabolic flexibility was lower in T2DM-non-NAFL subjects (P=0.047) and NAFL subjects (P=0.059) compared with CON subjects. Adipo-IRi (r=0.652, P<0.001), hepatic insulin resistance index (HIRi) (r=0.576, P=0.001), and ΔRd (r=−0.653, P<0.001) correlated with IHL content. Individuals with NAFL suffer from metabolic perturbations to a similar degree as T2DM patients. NAFL is an important feature leading to severe insulin resistance and should be viewed as a serious health threat for the development of T2DM. ClinicalTrials.gov: NCT01317576
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,670
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
Table of nonprotein respiratory quotient: an update.
Péronnet, F., & Massicotte, D. (1991) · PubMed · Cited by 1,209
Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017
Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002
Self-citationIntrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904944106 · Cited by 972
Variability of Aerobic Performance in the Laboratory and Its Physiologic Correlates
Kuipers, H., Verstappen, F., Keizer, H., Geurten, P., & van Kranenburg, G. (1985) · International Journal of Sports Medicine · doi:10.1055/s-2008-1025839 · Cited by 884
Research works printed but not linked: 1
- Roden, 2006, Mechanisms of Disease: hepatic steatosis in type 2 diabetes–pathogenesis and clinical relevance. Nature clinical practice, Endocrinol. Metab., 2, 335
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Gastaldelli, A., Cusi, K., Fernández Landó, L., Bray, R., Brouwers, B., & Rodríguez, Á. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00070-5 · Cited by 513
Self-citationFrom NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
Gastaldelli, A., & Cusi, K. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.07.002 · Cited by 455
An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease
Lee, E., Korf, H., & Vidal-Puig, A. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.01.024 · Cited by 222
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
Lim, S., Kim, J.-W., & Targher, G. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.04.008 · Cited by 213
Roumans, K. H. M., Lindeboom, L., Veeraiah, P., Remie, C. M. E., Phielix, E., Havekes, B., Bruls, Y. M. H., Brouwers, M. C. G. J., Ståhlman, M., Alssema, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15684-0 · Cited by 138
Self-citationLipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
“31 In the early phases of MASLD, the impaired suppression of lipolysis by insulin is accompanied by increased FFA oxidation, 8,32 and mitochondrial activity and biogenesis are increased rather than decreased.”
Hepatic glucose metabolism in the steatotic liver
Scoditti, E., Sabatini, S., Carli, F., & Gastaldelli, A. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00888-8 · Cited by 134
“They found that, although fasting EGP was not different among the groups, individuals with SLD and without T2D ( n = 11) had reduced hepatic suppression of EGP similar to that in individuals with T2D with or without SLD ( n = 6 and n = 7, respectively) 43 .”
Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective
De Block, C., Bailey, C., Wysham, C., Hemmingway, A., Allen, S. E., & Peleshok, J. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14831 · Cited by 121
“people with type 2 diabetes, elevated liver fat content and increased visceral fat have been associated with an increased risk of cardiometabolic complications.(91,92) In the MRI substudy of SURPASS-3, tirzepatide”
BackgroundMancilla, R., Brouwers, B., Schrauwen‐Hinderling, V. B., Hesselink, M. K. C., Hoeks, J., & Schrauwen, P. (2020) · Physiological Reports · doi:10.14814/phy2.14669 · Cited by 127
“The baseline, metabolic characteristics of participants were previously reported in (Brouwers et al., 2017), whereas the effects of exercise training in obese and NAFL volunteers were reported in (Brouwers et al.”
BackgroundSelf-citationCrosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
Lim, S. K., Taskinen, M., & Borén, J. (2018) · Obesity Reviews · doi:10.1111/obr.12820 · Cited by 111
“In line with this, insulin‐ stimulated glucose disposal assessed by insulin clamping was lower in patients with NAFLD and T2D than in control subjects.(72) Compared with individuals with simple fatty liver, those with NASH had higher levels of sphingolipids, which are associated with oxidative stress, inflammation, an…”
ResultInsulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?
Gastaldelli, A. (2017) · Clinical Science · doi:10.1042/cs20170987 · Cited by 95
Pathophysiological role of metabolic flexibility on metabolic health
Galgani, J. E., & Fernández‐Verdejo, R. (2021) · Obesity Reviews · doi:10.1111/obr.13131 · Cited by 90
Brouwers, B., Schrauwen-Hinderling, V. B., Jelenik, T., Gemmink, A., Sparks, L. M., Havekes, B., Bruls, Y., Dahlmans, D., Roden, M., Hesselink, M. K. C., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00266.2017 · Cited by 69
“hepatic, and skeletal muscle insulin resistance (6, 13, 21, 25).”
BackgroundResultSelf-citationGuerra, S., Mocciaro, G., & Gastaldelli, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13695 · Cited by 65
Stephens, N. A., Brouwers, B., Eroshkin, A. M., Yi, F., Cornnell, H. H., Meyer, C., Goodpaster, B. H., Pratley, R. E., Smith, S. R., & Sparks, L. M. (2018) · Diabetes Care · doi:10.2337/dc18-0296 · Cited by 46
Self-citationCarli, F., Sabatini, S., Gaggini, M., Sironi, A. M., Bedogni, G., & Gastaldelli, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914651 · Cited by 48
“This confirms previous results that showed an association between the severity of MASLD and insulin resistance measured during fasting conditions as HOMA-IR [57,58], during OGTT as Matsuda or OGIS index [58–60], or during a clamp [26,61].”
Gemmink, A., Daemen, S., Brouwers, B., Huntjens, P. R., Schaart, G., Moonen‐Kornips, E., Jörgensen, J. A., Hoeks, J., Schrauwen, P., & Hesselink, M. K. C. (2017) · The Journal of Physiology · doi:10.1113/jp275182 · Cited by 46
“All subjects provided their written informed consent before participation and were selected from a larger cohort (Vosselman et al. 2015; Brouwers et al. 2017).”
BackgroundMethodSelf-citationWang, J. H., Geng, T., Zou, Q., Yang, N., Zhao, W., Li, Y., Tan, X., Yuan, T., Liu, X., & Liu, Z. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103857 · Cited by 41
Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease
Fontes, A., Pagès, M. A. I., Oliveira, P. J., Ramalho‐Santos, J., Zischka, H., & Azul, A. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163987 · Cited by 40
“Of note, indeed NAFLD patients present a “metabolic inflexibility”, that is, a reduced capacity to switch back from FFA to glucose oxidation, even in the presence of insulin [43,46,97].”
BackgroundInsulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM
Colosimo, S., Mitra, S. K., Chaudhury, T., & Marchesini, G. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111016 · Cited by 38
Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
Mocciaro, G., & Gastaldelli, A. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_573 · Cited by 46
Sabatini, S., Sen, P., Carli, F., Pezzica, S., Rosso, C., Lembo, E., Verrastro, O., Daly, A. K., Govaere, O., Cockell, S., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101820 · Cited by 45
Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosis
Airaghi, L., Rango, M., Maira, D., Barbieri, V., Valenti, L. V. C., Lombardi, R., Biondetti, P. R., Fargion, S. R., & Fracanzani, A. L. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.11.012 · Cited by 32
Ang, J.-H. C., Sun, L., Foo, S.-Y. R., Leow, M. K., Vidal‐Puig, A., Fontana, L., & Dalakoti, M. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102354 · Cited by 36
“40 Compared to individuals with normal intrahepatic lipid content, those with steatosis had reduced rates of insulin-stimulated glucose disposal and inappropriate low FAO for the excess of lipid accumulation.”
Gemmink, A., Daemen, S., Brouwers, B., Hoeks, J., Schaart, G., Knoops, K., Schrauwen, P., & Hesselink, M. K. C. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158852 · Cited by 25
Self-citationD-Pinitol Increases Insulin Secretion and Regulates Hepatic Lipid Metabolism in Msg-Obese Mice
JÚNIOR, J. A. D. S., SILVA, A. C. V. F. D., Figueiredo, L. S., Araújo, T. R., Freitas, I. N., Carneiro, E. M., Ribeiro, E. D. S., & Ribeiro, R. A. (2020) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202020201382 · Cited by 22
Giannakogeorgou, A., Roden, M., & Pafili, K. (2025) · HORMONES · doi:10.1007/s42000-025-00701-y · Cited by 24
Self-citationMazi, T. A., Borkowski, K., Newman, J. W. I., Fiehn, O., Bowlus, C. L., Sarkar, S., Matsukuma, K. E., Ali, M. R., Kieffer, D. A., Wan, Y. Y., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.06.024 · Cited by 19
Chatterjee, A., Basu, A., Das, K., Singh, P., Mondal, D., Bhattacharya, B., Roychoudhury, S., Majumder, P. P., Chowdhury, A., & Basu, P. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.06.009 · Cited by 16
Bello, O., Ladwa, M., Hakim, O., Marathe, C. S., Shojaee‐Moradie, F., Charles‐Edwards, G., Peacock, J. L., Umpleby, A. M., Amiel, S. A., & Goff, L. M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0636 · Cited by 15
Salidroside and Curcumin Formula Prevents Liver Injury in Nonalcoholic Fatty Liver Disease in Rats
Li, H., Ying, H., & He, Z.-Y. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0012.3135 · Cited by 14
Herrera-Ojeda, J. L., Blanco-Palma, R. S., Chávez-Tapia, N. C., Uribe, M., Montalvo-Jave, E. E., & Nuño‐Lámbarri, N. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02621-5 · Cited by 16
“[ 49 , 50 ] The redistribution of lipid sources in MASLD—particu - larly the increased contribution of FFAs from adipose tissue and upregulated de novo lipogenesis—is well-established, primarily supported by human tracer studies and biopsy data in T2DM and MASLD, and likely applicable to T1DM by…”
Metabolic drivers of MASLD and MASH: from hormonal imbalance to fibrosis
Gastaldelli, A., Scoditti, E., & Macedo, M. P. (2026) · Diabetologia · doi:10.1007/s00125-026-06774-7 · Cited by 12
“Such regulation depends on coordinated hormonal control, including insulin-mediated suppression of lipolysis and catecholamine-driven lipid mobilisation [5, 6].”
Shinde, S., Nelson, D. R., Mitroi, J., Heaton, P. C., Hincapie, A. L., & Brouwers, B. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2279676 · Cited by 12
Self-citationBruls, Y. M. H., den Kamp, Y. J. M. O., Veeraiah, P., Perez, R. Z., Phielix, E., Havekes, B., Schaart, G., Moonen‐Kornips, E., Berendsen, B. R. B., Virmani, A., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16298 · Cited by 10
“Since hepatic insulin resistance is associated with increased ectopic lipid deposition in the liver, 45 we investigated whether a reduced IHL content is underlying the improvements in hepatic insulin sensitivity after carnitine supplementation.”
Self-citationYalcin, E. B., Tong, M., Cao, K., Huang, C., & de la Monte, S. M. (2023) · European Journal of Biology and Biotechnology · doi:10.24018/ejbio.2023.4.1.135 · Cited by 10
Are Individuals With Type 2 Diabetes Metabolically Inflexible? A Systematic Review and Meta‐Analysis
Hansen, M., Lange, K. K., Stausholm, M. B., & Dela, F. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70044 · Cited by 9
Gignac, T., Trépanier, G., Pradeau, M., Morissette, A., Agrinier, A.-L., Larose, É., Marois, J., Pilon, G., Gagnon, C., Vohl, M., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00294.2023 · Cited by 8
Roumans, K. H. M., Veelen, A., Andriessen, C., Mevenkamp, J., Moonen‐Kornips, E., Veeraiah, P., Havekes, B., Peters, H. P. F., Lindeboom, L., Schrauwen, P., et al. (2023) · Obesity · doi:10.1002/oby.23676 · Cited by 8
“increased adipose tissue insulin resistance [27], which can contribute to increased glycerol flux and thereby provide gluconeogenic substrates.”
BackgroundSelf-citationReappraisal of attenuated insulin sensitivity in the evolution of non-alcoholic fatty liver disease
Miyakoshi, T., Sagesaka, H., Sato, Y., Hirbayashi, K., Koike, H., Yamashita, K., Usuda, S., Kiyosawa, K., Shimodaira, M., & Aizawa, T. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0246-3 · Cited by 5
NAFLD and Insulin Resistance: A Multisystemic Disease
Gastaldelli, A. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_4 · Cited by 4
Basset‐Sagarminaga, J., van de Weijer, T., Koene, E., Bruls, Y. M. H., Phielix, E., Brouwers, K., Springer, S., Johansson, E., Johansson, L. O. M., Kotasidis, F. A., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112288 · Cited by 3
Self-citationSotorník, R., Suissa, R., & Ardilouze, J. (2022) · Clinical Diabetes · doi:10.2337/cd21-0044 · Cited by 3
Liu, D., Yin, M., Chen, J., Fu, C., Schneider, M., Nickel, D. M., & Yao, X. (2024) · NMR in Biomedicine · doi:10.1002/nbm.5290 · Cited by 3
Metabolic Syndrome and Metabolic Dysfunction‐Associated Fatty Liver Disease
Koo, B. K., & Lim, S. K. (2022) · Wiley eBooks · doi:10.1002/9781119695257.ch13 · Cited by 3
Repurposing levothyroxine for managing metabolic dysfunction-associated steatotic liver disease
Duntas, L. H., Pοlyzos, S. A., Gottwald‐Hostalek, U., Urgatz, B., & Yen, P. M. (2025) · Endocrine · doi:10.1007/s12020-025-04451-0 · Cited by 2
“In euthyroid individuals with MASH, there is a decreased conversion of prohormone T4 to bioactive T3 and an increased conver - sion of T4 to the inactive metabolite reverse T3 [58].”
Koene, E., Schrauwen‐Hinderling, V. B., Basset‐Sagarminaga, J., Brouwers, K., Bruls, Y. M. H., Mevenkamp, J., Haans, F., Schaart, G., Moonen‐Kornips, E., Jörgensen, J. A., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01626-5 · Cited by 2
“Increased circulating follistatin levels are associated with an increased risk of T2D in humans and have been shown to induce adipose tissue insulin resistance in mice 27,28 .”
InfluentialSelf-citationImaging in Precision Medicine for Diabetes
Zaharia, O., Schrauwen‐Hinderling, V. B., & Roden, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_4 · Cited by 1
Self-citationAzar, P. S., Akhlaghi, S., Shariat‐Madar, Z., & Mahdi, F. (2026) · Biomolecules · doi:10.3390/biom16040535 · Cited by 2
“This highlights the significant roles of triglycerides [10], insulin [11], and angiotensin‑related molecules [12] in their respective target tissues.”
Koudelková, K., Moro, C., & Gojda, J. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70068 · Cited by 1
Lima, V. C. F. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.100.2018.tde-18122017-094146
Acetylcarnitine: The role in metabolic exibility and insulin sensitivity
Bruls, Y. M. H. (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180614yb
Self-citationAn exploration into the proteins that regulate skeletal muscle lipid metabolism
Whytock, K. L. (2021) · Liverpool John Moores University · doi:10.24377/ljmu.t.00009962 · Cited by 2
Roumans, K. H. M. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210915kr
Novel aspects of exercise training to promote human metabolic health
Mancilla, R. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220210rm
Magnetic resonance spectroscopy to unravel metabolic alterations in hepatic steatosis in humans
Veeraiah, P. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210701pv
Hu, R., Xu, S., Han, S., Jing, C., Jia, A., Yu, X., Xing, Y., Liang, S., Ming, J., & Ji, Q. (2019) · doi:10.21203/rs.2.16214/v1
A metabolically healthy lifestyle: A matter of timing?
Andriessen, C. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20230706ca
Hsu, S., Chen, C.-L., Liu, C.-T., Lo, H., Liu, Y.-K., Gao, P.-S., Huang, S.-K., & Hsu, C.-W. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2025.2360
“Hepatic insulin resistance often coincides with hepatic steatosis, characterized by excessive fatty acid uptake and enhanced de novo lipogenesis in the liver [37,38].”
Metadata
- Authors
- Brouwers, B., Schrauwen-Hinderling, V. B., Jelenik, T., Gemmink, A., Havekes, B., Bruls, Y., Dahlmans, D., Roden, M., Hesselink, M. K. C., & Schrauwen, P.
- Affiliations
- Maastricht University Medical Centre (NL)
- NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University Düsseldorf, Düsseldorf, Germany
- Deutsches Diabetes-Zentrum e.V. (DE)
- Corresponding author
- Schrauwen, Patrick
- ORCID
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2017-07-07
- Volume
- 131
- Issue
- 15
- Pages
- 1905-1917
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2626282634
- Cited by
- 59
- References
- 52
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 4 · 2023: 8 · 2022: 7 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 4
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (acceptedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 1116)
- Diabetes Fonds (2009.60.003)
- Maastricht Universitair Medisch Centrum
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- non-alcoholic fatty liver disease, type 2 diabetes, insulin resistance, hepatic insulin resistance, metabolic flexibility, hyperinsulinemic-euglycemic clamp, intrahepatic lipid, adipose tissue insulin sensitivity, free fatty acids, endogenous glucose production, glucose disposal, hepatic glucose production, hepatic lipogenesis, hepatic de novo lipogenesis, hepatic glucose uptake
- MeSH terms
- Adipose Tissue, Adult, Aged, Body Composition, Diabetes Mellitus, Type 2, Humans, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Magnetic Resonance Spectroscopy, Glucose Clamp Technique, Muscle, Skeletal, Lipid Metabolism, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.